News for Basilea Pharmaceutica AG (BSLN.SW)

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NBSLN.S - Basilea Pharmaceutica AG AllschwilFull Year 2024 Basilea Pharmaceutica AG Allschwil E

Basilea Pharmaceutica AG (OTC:BPMUF) Q4 2024 Earnings Conference Call February 18, 2025 10:00 AM ETCompany ParticipantsDavid Veitch - Chief Executive...

Allschwil, 10. Oktober 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und...

Aug 13, 2024 / 02:00PM GMTDavid Veitch - Basilea Pharmaceutica AG Allschwil - Chief Executive Officer, Member of the Management Committee Thank you, and hello,

Basilea Pharmaceutica AG (OTC:BPMUF) Q2 2024 Results Conference Call August 13, 2024 10:00 AM ETCompany ParticipantsDavid Veitch - Chief Executive...

Allschwil, 20. Juni 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem...

Creating anti-infective opportunities Patients are at the heart of what we do Investor presentation ...

Dow Jones Newswires March 11, 2024 02:15 ET ...

Nov 13, 2023 / 03:00PM GMTOperator Ladies and gentlemen, welcome to the Basilea Pharmaceutica Acquisition of Fosmanogepix Conference Call and Live Webcast. I am

Aug 15, 2023 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Basilea Pharmaceuticals Half Year Results 2023 Conference Call and Live Webcast. I am Al

Aug 16, 2022 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Basilea Pharmaceutica Half Year Results 2022 Conference Call and Live Webcast. I am Sand

Jun 28, 2022 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the webcast on the positive top line results of Phase III ERADICATE study in SAB. I'm Alice,

Read Head-To-Head Analysis: Basilea Pharmaceutica (OTCMKTS:BPMUF) versus Avalo Therapeutics (NASDAQ:AVTX) at ETF Daily News